![Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial | Annals of the Rheumatic Diseases Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial | Annals of the Rheumatic Diseases](https://ard.bmj.com/sites/default/files/highwire/annrheumdis/82/8.cover-source.jpg)
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial | Annals of the Rheumatic Diseases
![Amazon.com: Light Therapy Lamp, UV-Free 10000 Lux Therapy Light Daylight Lamp Touch Control with 3 Adjustable Brightness Levels & 4 Timer Function, Large Light Surface & Rotatable Stand for Home/Office : Health Amazon.com: Light Therapy Lamp, UV-Free 10000 Lux Therapy Light Daylight Lamp Touch Control with 3 Adjustable Brightness Levels & 4 Timer Function, Large Light Surface & Rotatable Stand for Home/Office : Health](https://m.media-amazon.com/images/I/51xtoyr-ohL._AC_UF1000,1000_QL80_.jpg)
Amazon.com: Light Therapy Lamp, UV-Free 10000 Lux Therapy Light Daylight Lamp Touch Control with 3 Adjustable Brightness Levels & 4 Timer Function, Large Light Surface & Rotatable Stand for Home/Office : Health
![PDF) Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis PDF) Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis](https://i1.rgstatic.net/publication/346880188_Clinical_predictors_of_multiple_failure_to_biological_therapy_in_patients_with_rheumatoid_arthritis/links/5fd1b1c8a6fdcc697bf2acba/largepreview.png)
PDF) Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis
![IJERPH | Free Full-Text | Irradiation with Polychromatic Incoherent Low Energy Radiation of Human Peripheral Blood Mononuclear Cells In Vitro: Effects on Cytokine Production IJERPH | Free Full-Text | Irradiation with Polychromatic Incoherent Low Energy Radiation of Human Peripheral Blood Mononuclear Cells In Vitro: Effects on Cytokine Production](https://www.mdpi.com/ijerph/ijerph-17-01233/article_deploy/html/images/ijerph-17-01233-g001-550.jpg)
IJERPH | Free Full-Text | Irradiation with Polychromatic Incoherent Low Energy Radiation of Human Peripheral Blood Mononuclear Cells In Vitro: Effects on Cytokine Production
![Mapping of Translocator Protein (18 kDa) in Peripheral Sterile Inflammatory Disease and Cancer through PET Imaging | Molecular Pharmaceutics Mapping of Translocator Protein (18 kDa) in Peripheral Sterile Inflammatory Disease and Cancer through PET Imaging | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.1c00002/asset/images/large/mp1c00002_0001.jpeg)
Mapping of Translocator Protein (18 kDa) in Peripheral Sterile Inflammatory Disease and Cancer through PET Imaging | Molecular Pharmaceutics
![Upregulation of heat shock protein 27 confers resistance to actinomycin D‐induced apoptosis in cancer cells - Ma - 2013 - The FEBS Journal - Wiley Online Library Upregulation of heat shock protein 27 confers resistance to actinomycin D‐induced apoptosis in cancer cells - Ma - 2013 - The FEBS Journal - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/a25f85d9-ac1a-498c-9ec2-55ccbc3a5038/febs12432-fig-0004-m.jpg)
Upregulation of heat shock protein 27 confers resistance to actinomycin D‐induced apoptosis in cancer cells - Ma - 2013 - The FEBS Journal - Wiley Online Library
Mapping of Translocator Protein (18 kDa) in Peripheral Sterile Inflammatory Disease and Cancer through PET Imaging | Molecular Pharmaceutics
![Upregulation of heat shock protein 27 confers resistance to actinomycin D‐induced apoptosis in cancer cells - Ma - 2013 - The FEBS Journal - Wiley Online Library Upregulation of heat shock protein 27 confers resistance to actinomycin D‐induced apoptosis in cancer cells - Ma - 2013 - The FEBS Journal - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/62de2143-8a39-4bb3-964d-f9f713436020/febs12432-toc-0001-m.jpg?trick=1687847358239)
Upregulation of heat shock protein 27 confers resistance to actinomycin D‐induced apoptosis in cancer cells - Ma - 2013 - The FEBS Journal - Wiley Online Library
![PDF) Is There a Symmetry in Disease Control and Quality of Life of Patients with Rheumatoid Arthritis Treated with Biological Therapy? PDF) Is There a Symmetry in Disease Control and Quality of Life of Patients with Rheumatoid Arthritis Treated with Biological Therapy?](https://i1.rgstatic.net/publication/350406353_Is_There_a_Symmetry_in_Disease_Control_and_Quality_of_Life_of_Patients_with_Rheumatoid_Arthritis_Treated_with_Biological_Therapy/links/609c1c9692851c44a2c19605/largepreview.png)
PDF) Is There a Symmetry in Disease Control and Quality of Life of Patients with Rheumatoid Arthritis Treated with Biological Therapy?
![Frontiers | Residual Pain in the Context of Selecting and Switching Biologic Therapy in Inflammatory Rheumatic Diseases Frontiers | Residual Pain in the Context of Selecting and Switching Biologic Therapy in Inflammatory Rheumatic Diseases](https://www.frontiersin.org/files/Articles/712645/fmed-08-712645-HTML/image_m/fmed-08-712645-g001.jpg)
Frontiers | Residual Pain in the Context of Selecting and Switching Biologic Therapy in Inflammatory Rheumatic Diseases
![PDF) Residual Pain in the Context of Selecting and Switching Biologic Therapy in Inflammatory Rheumatic Diseases PDF) Residual Pain in the Context of Selecting and Switching Biologic Therapy in Inflammatory Rheumatic Diseases](https://i1.rgstatic.net/publication/353953483_Residual_Pain_in_the_Context_of_Selecting_and_Switching_Biologic_Therapy_in_Inflammatory_Rheumatic_Diseases/links/611bc5511e95fe241ada7e49/largepreview.png)
PDF) Residual Pain in the Context of Selecting and Switching Biologic Therapy in Inflammatory Rheumatic Diseases
![Functional FCGR3A 158 V/F and IL-6 −174 C/G polymorphisms predict response to biologic therapy in patients with rheumatoid arthritis: a meta-analysis | SpringerLink Functional FCGR3A 158 V/F and IL-6 −174 C/G polymorphisms predict response to biologic therapy in patients with rheumatoid arthritis: a meta-analysis | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00296-014-3015-1/MediaObjects/296_2014_3015_Fig2_HTML.gif)